Download PDF
Semin Thromb Hemost 2017; 43(07): 742-749
DOI: 10.1055/s-0037-1603364
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Hemostatic Complications in Renal Transplantation

Daniela Poli
1   Thrombosis Centre, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy
,
Emilia Antonucci
2   Clinical Study Section, Arianna Anticoagulazione Foundation, Bologna Italy
,
Maria Zanazzi
3   Renal Unit, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
13 June 2017 (online)

    Permissions and Reprints

Abstract

Chronic kidney disease (CKD) represents the irreversible loss of the excretory and homeostatic functions of the kidney. Renal transplantation is the preferred treatment for patients with advanced CKD. Despite the availability of more effective immunosuppressive drugs and the improvements in surgical techniques, the development of complications can compromise early and long-term outcomes of renal transplantation. In particular, bleeding and thrombotic disorders can have impact on patient and graft survival. Risk stratification, early diagnosis, and appropriate interventions are critical to the management of these complications. Renal arterial and vein thrombosis are the most common vascular complications in the early phase after transplantation, whereas renal artery stenosis is a late event mainly related to surgery. Standard heparin thromboprophylaxis should be adopted in the perioperative period. Among renal transplant recipients, a high risk of venous thromboembolism (VTE) is reported. This risk persists long after transplantation, and patients with a previous episode of VTE are also at high risk for recurrence. An extended anticoagulant treatment should be considered, balancing the bleeding risk in a given patient. To date, the use of vitamin K antagonists remains preferred, given the risk of pharmacological interference with immunosuppressive agents and the renal metabolism of direct oral anticoagulants. In this review, bleeding and thrombotic complications of renal transplantation are described, and recommended thromboprophylaxis is discussed.

Keywords

renal transplantation - venous thromboembolism - bleeding - thromboprophylaxis
 

  • References

  • 1 Ponticelli Ced. Thrombotic complications. In: Medical Complications of Kidney Transplantation. Boca Raton, FL: CRC Press Taylor & Francis Group; 2007: 409-415
    Google Scholar
  • 2 Pavord S, Myers B. Bleeding and thrombotic complications of kidney disease. Blood Rev 2011; 25 (06) 271-278
    CrossrefPubMedGoogle Scholar
  • 3 Gangji AS, Sohal AS, Treleaven D, Crowther MA. Bleeding in patients with renal insufficiency: a practical guide to clinical management. Thromb Res 2006; 118 (03) 423-428
    CrossrefPubMedGoogle Scholar
  • 4 Collins AJ, Foley RN, Herzog C. , et al. US Renal Data System 2012 Annual Data Report. Am J Kidney Dis 2013; 61 (01) (Suppl. 01) A7 , e1–e476
    CrossrefPubMedGoogle Scholar
  • 5 Segarra A, Chacón P, Martinez-Eyarre C. , et al. Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis. J Am Soc Nephrol 2001; 12 (06) 1255-1263
    PubMedGoogle Scholar
  • 6 Matsuo T, Koide M, Kario K, Suzuki S, Matsuo M. Extrinsic coagulation factors and tissue factor pathway inhibitor in end-stage chronic renal failure. Haemostasis 1997; 27 (04) 163-167
    PubMedGoogle Scholar
  • 7 Małyszko J, Małyszko JS, Myśliwiec M. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis. Kidney Blood Press Res 2004; 27 (02) 71-77
    CrossrefPubMedGoogle Scholar
  • 8 Kazory A, Ducloux D. Acquired hypercoagulable state in renal transplant recipients. Thromb Haemost 2004; 91 (04) 646-654
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Astrup AS, Tarnow L, Pietraszek L. , et al. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate. Diabetes Care 2008; 31 (06) 1170-1176
    CrossrefPubMedGoogle Scholar
  • 10 Ocak G, Vossen CY, Lijfering WM. , et al. Role of hemostatic factors on the risk of venous thrombosis in people with impaired kidney function. Circulation 2014; 129 (06) 683-691
    CrossrefPubMedGoogle Scholar
  • 11 Andrassy K. Kidney and haemostasis. A (personal) time-journey. Hamostaseologie 2015; 35 (01) 73-76
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Hedges SJ, Dehoney SB, Hooper JS, Amanzadeh J, Busti AJ. Evidence-based treatment recommendations for uremic bleeding. Nat Clin Pract Nephrol 2007; 3 (03) 138-153
    PubMedGoogle Scholar
  • 13 Rosendaal FR, Reitsma PH. Genetics of venous thrombosis. J Thromb Haemost 2009; 7 (Suppl. 01) 301-304
    CrossrefPubMedGoogle Scholar
  • 14 Parajuli S, Lockridge JB, Langewisch ED, Norman DJ, Kujovich JL. Hypercoagulability in kidney transplant recipients. Transplantation 2016; 100 (04) 719-726
    CrossrefPubMedGoogle Scholar
  • 15 Poli D, Zanazzi M, Antonucci E. , et al. High rate of recurrence in renal transplant recipients after a first episode of venous thromboembolism. Transplantation 2005; 80 (06) 789-793
    CrossrefPubMedGoogle Scholar
  • 16 Ducloux D, Pellet E, Fournier V. , et al. Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients. Transplantation 1999; 67 (01) 90-93
    CrossrefPubMedGoogle Scholar
  • 17 Vaidya S, Sellers R, Kimball P. , et al. Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome: a multicenter study. Transplantation 2000; 69 (07) 1348-1352
    CrossrefPubMedGoogle Scholar
  • 18 Vaidya S. Ten-yr renal allograft survival of patients with antiphospholipid antibody syndrome. Clin Transplant 2012; 26 (06) 853-856
    CrossrefPubMedGoogle Scholar
  • 19 Irish A. Renal allograft thrombosis: can thrombophilia explain the inexplicable?. Nephrol Dial Transplant 1999; 14 (10) 2297-2303
    CrossrefPubMedGoogle Scholar
  • 20 Yang Y, Lv J, Zhou F. , et al. Risk factors of pulmonary thrombosis/embolism in nephrotic syndrome. Am J Med Sci 2014; 348 (05) 394-398
    CrossrefPubMedGoogle Scholar
  • 21 Stevens SM, Woller SC, Bauer KA. , et al. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. J Thromb Thrombolysis 2016; 41 (01) 154-164
    CrossrefPubMedGoogle Scholar
  • 22 Friedman GS, Meier-Kriesche HU, Kaplan B. , et al. Hypercoagulable states in renal transplant candidates: impact of anticoagulation upon incidence of renal allograft thrombosis. Transplantation 2001; 72 (06) 1073-1078
    CrossrefPubMedGoogle Scholar
  • 23 Pherwani AD, Winter PC, McNamee PT. , et al. Is screening for factor V Leiden and prothrombin G20210A mutations in renal transplantation worthwhile? Results of a large single-center U.K. study. Transplantation 2003; 76 (03) 603-605
    CrossrefPubMedGoogle Scholar
  • 24 Middeldorp S. Inherited thrombophilia: a double-edged sword. Hematology (Am Soc Hematol Educ Program) 2016; 2016 (01) 1-9
    CrossrefPubMedGoogle Scholar
  • 25 Lempinen M, Stenman J, Kyllönen L, Salmela K. Surgical complications following 1670 consecutive adult renal transplantations: a single center study. Scand J Surg 2015; 104 (04) 254-259
    CrossrefPubMedGoogle Scholar
  • 26 Pillot P, Bardonnaud N, Lillaz J. , et al. Risk factors for surgical complications after renal transplantation and impact on patient and graft survival. Transplant Proc 2012; 44 (09) 2803-2808
    CrossrefPubMedGoogle Scholar
  • 27 Szabo-Pap M, Zadori G, Fedor R. , et al. Surgical complications following kidney transplantations: a single-center study in Hungary. Transplant Proc 2016; 48 (07) 2548-2551
    CrossrefPubMedGoogle Scholar
  • 28 Eufrásio P, Parada B, Moreira P. , et al. Surgical complications in 2000 renal transplants. Transplant Proc 2011; 43 (01) 142-144
    CrossrefPubMedGoogle Scholar
  • 29 Dimitroulis D, Bokos J, Zavos G. , et al. Vascular complications in renal transplantation: a single-center experience in 1367 renal transplantations and review of the literature. Transplant Proc 2009; 41 (05) 1609-1614
    CrossrefPubMedGoogle Scholar
  • 30 Risaliti A, Sainz-Barriga M, Baccarani U. , et al. Surgical complications after kidney transplantation [in Italian]. G Ital Nefrol 2004; 21 (Suppl. 26) S43-S47
    PubMedGoogle Scholar
  • 31 Giustacchini P, Pisanti F, Citterio F, De Gaetano AM, Castagneto M, Nanni G. Renal vein thrombosis after renal transplantation: an important cause of graft loss. Transplant Proc 2002; 34 (06) 2126-2127
    CrossrefPubMedGoogle Scholar
  • 32 Humar A, Matas AJ. Surgical complications after kidney transplantation. Semin Dial 2005; 18 (06) 505-510
    CrossrefPubMedGoogle Scholar
  • 33 Ponticelli C, Moia M, Montagnino G. Renal allograft thrombosis. Nephrol Dial Transplant 2009; 24 (05) 1388-1393
    CrossrefPubMedGoogle Scholar
  • 34 Patel NH, Jindal RM, Wilkin T. , et al. Renal arterial stenosis in renal allografts: retrospective study of predisposing factors and outcome after percutaneous transluminal angioplasty. Radiology 2001; 219 (03) 663-667
    CrossrefPubMedGoogle Scholar
  • 35 Bruno S, Remuzzi G, Ruggenenti P. Transplant renal artery stenosis. J Am Soc Nephrol 2004; 15 (01) 134-141
    CrossrefPubMedGoogle Scholar
  • 36 Ngo AT, Markar SR, De Lijster MS, Duncan N, Taube D, Hamady MS. A systematic review of outcomes following percutaneous transluminal angioplasty and stenting in the treatment of transplant renal artery stenosis. Cardiovasc Intervent Radiol 2015; 38 (06) 1573-1588
    CrossrefPubMedGoogle Scholar
  • 37 Patrono D, Verhelst R, Buemi A, Darius T, Godefroid N, Mourad M. Presentation and management of mycotic pseudoaneurysm after kidney transplantation. Transpl Infect Dis 2015; 17 (01) 129-136
    CrossrefPubMedGoogle Scholar
  • 38 Mezzetto L, Boschiero L, Fior F. , et al. Direct revascularization with autotransplant technique for a true aneurysm of the renal artery 20 years after kidney transplantation. Ann Vasc Surg 2016; 32: 132.e5-132.e8
    CrossrefPubMedGoogle Scholar
  • 39 Sartori MT, Rigotti P, Marchini F. , et al. Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy. Transplantation 2003; 75 (07) 994-998
    PubMedGoogle Scholar
  • 40 Poli D, Zanazzi M, Antonucci E. , et al. Renal transplant recipients are at high risk for both symptomatic and asymptomatic deep vein thrombosis. J Thromb Haemost 2006; 4 (05) 988-992
    CrossrefPubMedGoogle Scholar
  • 41 Abbott KC, Cruess DF, Agodoa LY, Sawyers ES, Tveit DP. Early renal insufficiency and late venous thromboembolism after renal transplantation in the United States. Am J Kidney Dis 2004; 43 (01) 120-130
    CrossrefPubMedGoogle Scholar
  • 42 Abualhassan N, Aljiffry M, Thalib L, Coussa R, Metrakos P, Hassanain M. Post-transplant venous thromboembolic events and their effect on graft survival. Saudi J Kidney Dis Transpl 2015; 26 (01) 1-5
    CrossrefPubMedGoogle Scholar
  • 43 Humar A, Johnson EM, Gillingham KJ. , et al. Venous thromboembolic complications after kidney and kidney-pancreas transplantation: a multivariate analysis. Transplantation 1998; 65 (02) 229-234
    PubMedGoogle Scholar
  • 44 Douketis JD, Spyropoulos AC. , et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e326S-e350S
    CrossrefPubMedGoogle Scholar
  • 45 Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ. ; PREVENT Medical Thromboprophylaxis Study Group. Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost 2005; 93 (01) 76-79
    Article in Thieme ConnectPubMedGoogle Scholar
  • 46 Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9 (Suppl. 03) S1-S155
    PubMedGoogle Scholar
  • 47 Keller AK, Jorgensen TM, Jespersen B. Identification of risk factors for vascular thrombosis may reduce early renal graft loss: a review of recent literature. J Transplant 2012; 2012: 793461
    PubMedGoogle Scholar
  • 48 Vlahakos DV, Marathias KP, Agroyannis B, Madias NE. Posttransplant erythrocytosis. Kidney Int 2003; 63 (04) 1187-1194
    CrossrefPubMedGoogle Scholar
  • 49 Kearon C, Akl EA, Ornelas J. , et al. Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report. Chest 2016; 149 (02) 315-352
    CrossrefPubMedGoogle Scholar
  • 50 Pawlicki J, Cierpka L, Król R, Ziaja J. Risk factors for early hemorrhagic and thrombotic complications after kidney transplantation. Transplant Proc 2011; 43 (08) 3013-3017
    CrossrefPubMedGoogle Scholar
  • 51 Ng JC, Leung M, Landsberg D. Evaluation of Heparin Anticoagulation Protocols in Post-Renal Transplant Recipients (EHAP-PoRT Study). Can J Hosp Pharm 2016; 69 (02) 114-121
    PubMedGoogle Scholar
  • 52 Ringenberg T, Desanto H, Opsha Y, Costello J, Schiller D. Evaluation of bleeding rates in renal transplant patients on therapeutic intravenous heparin. Hosp Pharm 2013; 48 (11) 936-957
    CrossrefPubMedGoogle Scholar
  • 53 Shen E, Uemura T, Kadry Z, Sathishkumar S. Successful living donor kidney transplantation in a patient with prothrombin gene mutation: Case report and literature review. J Anaesthesiol Clin Pharmacol 2014; 30 (01) 106-108
    CrossrefPubMedGoogle Scholar
  • 54 Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. ; American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 454S-545S
    CrossrefPubMedGoogle Scholar